RBC Capital Mkts slashes price target on Medtronic plc [MDT] – find out why.

Medtronic plc [NYSE: MDT] price plunged by -1.77 percent to reach at -$1.48. The company report on March 6, 2023 that Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


ACC.23/WCC late-breaking data: PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent atrial fibrillation.

– Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its PulseSelect™ Pulsed Field Ablation (PFA) System exceeded its safety performance goal, with an adverse event rate of 0.7%, one of the lowest adverse event rates of any prior U.S. FDA Investigational Device Exemption (IDE) trial for atrial fibrillation (AF) ablation or any multi-center PFA study. PULSED AF exceeded the threshold for its efficacy performance goal and further, clinical success, freedom from recurrence of any symptomatic atrial arrhythmias, was at least 80% for each patient cohort. Findings from the PULSED AF Pivotal Trial were presented as a late-breaking trial today at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.23/WCC) and simultaneously published in Circulation.

A sum of 6845239 shares traded at recent session while its average daily volume was at 6.76M shares. Medtronic plc shares reached a high of $83.825 and dropped to a low of $81.45 until finishing in the latest session at $81.93.

The one-year MDT stock forecast points to a potential upside of 13.26. The average equity rating for MDT stock is currently 2.50, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Medtronic plc [MDT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $94.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

RBC Capital Mkts have made an estimate for Medtronic plc shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on January 09, 2023. While these analysts kept the previous recommendation, Oppenheimer raised their target price from $106 to $85. The new note on the price target was released on November 23, 2022, representing the official price target for Medtronic plc stock. Previously, the target price had yet another drop from $108 to $85, while Citigroup kept a Neutral rating on MDT stock.

The Average True Range (ATR) for Medtronic plc is set at 1.60, with the Price to Sales ratio for MDT stock in the period of the last 12 months amounting to 3.49. The Price to Book ratio for the last quarter was 2.12, with the Price to Cash per share for the same quarter was set at 8.49. Price to Free Cash Flow for MDT in the course of the last twelve months was 175.36 with Quick ratio for the last quarter at 1.40.

MDT Stock Performance Analysis:

Medtronic plc [MDT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.75. With this latest performance, MDT shares dropped by -6.45% in over the last four-week period, additionally sinking by -7.46% over the last 6 months – not to mention a drop of -23.89% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDT stock in for the last two-week period is set at 44.23, with the RSI for the last a single of trading hit 38.99, and the three-weeks RSI is set at 47.25 for Medtronic plc [MDT]. The present Moving Average for the last 50 days of trading for this stock 81.88, while it was recorded at 82.50 for the last single week of trading, and 86.30 for the last 200 days.

Insight into Medtronic plc Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Medtronic plc [MDT] shares currently have an operating margin of +19.53 and a Gross Margin at +62.88. Medtronic plc’s Net Margin is presently recorded at +15.91.

Return on Equity for this stock inclined to 9.69, with Return on Assets sitting at 5.48.

Medtronic plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.80.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic plc go to 2.18%.

Medtronic plc [MDT] Insider Position Details

There are presently around $89,242 million, or 84.60% of MDT stock, in the hands of institutional investors. The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 125,126,702, which is approximately 1.021% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 122,290,951 shares of the stock with an approximate value of $10.02 billion in MDT stocks shares; and STATE STREET CORP, currently with $4.92 billion in MDT stock with ownership of nearly 1.762% of the company’s market capitalization.

Positions in Medtronic plc stocks held by institutional investors increased at the end of Tuesday and at the time of the Tuesday reporting period, where 898 institutional holders increased their position in Medtronic plc [NYSE:MDT] by around 61,971,834 shares. Additionally, 1,079 investors decreased positions by around 61,982,875 shares, while 165 investors held positions by with 965,288,666 shares. The mentioned changes placed institutional holdings at 1,089,243,375 shares, according to the latest SEC report filing. MDT stock had 200 new institutional investments in for a total of 6,434,038 shares, while 157 institutional investors sold positions of 8,300,433 shares during the same period.


Please enter your comment!
Please enter your name here